Pharmacy- Page 18

Roche ranked the most sustainable healthcare company in the DJSI

November 16, 2020

Pharmacy

The FINANCIAL — For the eleventh time, Roche has been recognised as the most sustainable company in the Pharmaceuticals index of the Dow Jones Sustainability Indices (DJSI). This is based on an in-depth analysis of economic, social and environmental performance. The DJSI family of indices serves as a benchmark for investors who integrate sustainability considerations into their portfolios. Roche has

Gilead and Novo Nordisk announced new data from proof-of-concept trial in NASH

The FINANCIAL — Gilead Sciences, Inc. and Novo Nordisk A/S announced results

by The FINANCIAL

November 16, 2020

2 mins read

Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer and Humboldt Fund

The FINANCIAL — Metagenomi, a next generation gene editing company launched by

by The FINANCIAL

November 12, 2020

1 min read

Pharmaceutical industries join to promise fair access to COVID-19 medicines and vaccines

The FINANCIAL — On the occasion of the World Health Assembly, the world’s

by The FINANCIAL

November 12, 2020

1 min read

Pharmacy

Novartis announces CEO Joseph Jimenez to retire from Novartis in 2018

The FINANCIAL -- Joseph Jimenez, Chief Executive Officer (CEO) of Novartis, has informed the Board of Directors of his desire to step down as CEO in 2018, after eight years in position.

by The FINANCIAL

September 5, 2017

2 mins read

Pharmacy

European Commission Approves Expanded Use Of Mimpara

The FINANCIAL -- Amgen on August 31 announced that the European Commission (EC) has granted Marketing Authorization of a pediatric formulation (granules in capsule for opening) of Mimpara (cinacalcet) for the treatment of secondary hyperparathyroidism (HPT) in children aged three years and

by The FINANCIAL

September 1, 2017

1 min read

Pharmacy

FDA approves Roche’s Actemra/RoActemra (tocilizumab)

The FINANCIAL -- Roche announced on August 30 that the US Food and Drug Administration (FDA) has approved Actemra/RoActemra® (tocilizumab) intravenous injection for the treatment of chimeric antigen receptor (CAR) T cell-induced severe or life-threatening cytokine release syndrome (CRS) in patients two

by The FINANCIAL

August 31, 2017

1 min read

Pharmacy

Novartis receives first ever FDA approval for a CAR-T cell therapy, Kymriah

The FINANCIAL -- Novartis announced on August 30 that the US Food and Drug Administration (FDA) has approved Kymriah(TM)(tisagenlecleucel) suspension for intravenous infusion, formerly CTL019, the first chimeric antigen receptor T cell (CAR-T) therapy, for the treatment of patients up to 25

by The FINANCIAL

August 31, 2017

3 mins read

Pharmacy

Lynparza receives additional and broad approval in the US for ovarian cancer

The FINANCIAL -- AstraZeneca and Merck & Co., Inc., (Merck: known as MSD outside the U.S. and Canada) on August 17 announced that the US Food and Drug Administration (FDA) has granted approval for the PARP inhibitor, Lynparza (olaparib), as follows:

by The FINANCIAL

August 18, 2017

2 mins read

Pharmacy

Changes in Novo Nordisk Executive Management

The FINANCIAL -- Novo Nordisk A/S on August 15 announced two changes to its Executive Management team.

by The FINANCIAL

August 15, 2017

1 min read

Pharmacy

Novo Nordisk increased reported operating profit by 8%

The FINANCIAL -- Sales within diabetes and obesity care increased by 11% to DKK 47.5 billion (10% in local currencies).

by The FINANCIAL

August 9, 2017

1 min read

Pharmacy

Teva Announces FDA Approval of QVAR RediHaler Inhalation Aerosol

The FINANCIAL -- Teva Pharmaceutical Industries Ltd. announced on August 7 that the U.S. Food and Drug Administration (FDA) has approved QVAR RediHaler (beclomethasone dipropionate HFA) inhalation aerosol, a breath-actuated inhaler for the maintenance treatment of asthma as a prophylactic therapy in

by The FINANCIAL

August 8, 2017

4 mins read

Pharmacy

AbbVie Receives U.S. FDA Approval of MAVYRET

The FINANCIAL -- AbbVie on August 3 announced that the U.S. Food and Drug Administration (FDA) approved MAVYRET (glecaprevir/pibrentasvir), a once-daily, ribavirin-free treatment for adults with chronic hepatitis C virus (HCV) infection across all major genotypes (GT1-6).

by The FINANCIAL

August 4, 2017

1 min read

Pharmacy

Bristol-Myers Squibb to Acquire IFM Therapeutics

The FINANCIAL -- Bristol-Myers Squibb Company and IFM Therapeutics (IFM) announced on August 3 that the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire all of the outstanding capital stock of IFM Therapeutics, a venture-backed biotech company focused

by The FINANCIAL

August 4, 2017

2 mins read